// App-Quantinova.ai

Mo1202 : Characterization of Anti-Tumor Necrosis Factor Agent-Induced Lupus in Patients With Inflammatory Bowel Disease

Researchers

Presenter

  • Laura Stinton

Principal Investigators

  • Remo Panaccione

  • Gilaad Kaplan

  • Subrata Ghosh

  • Carl A. Anderson

  • Bertus Eksteen

Medical Centers

  • Division of Nephrology, University of Calgary, Calgary, AB, Canada

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Cardiorenal syndrome

  • Crohn's disease

  • Pancreatitis

  • Inflammatory Arthritis

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved